utility

header_second

RegMed Investors (RMi) went exclusive on July 27th!

Your complimentary subscription to RegMed Investors’ (RMi) reporting on the stem, cell and gene therapy and RegMed sector has expired.

Whether information or intelligence is good, bad or somewhere in between; I put into context what is relevant and useful for investors.

It’s up to you to choose the level of content access to provide a premium experience and value - don’t wait to exhale!

I also bring fresh perspectives that yield a whole that is greater than the sum of the parts as I convey a spectrum of factors that explain outcomes, analytical principles and analysis without the encumbrance of trading, investment or I-Banking.

So, after these years of following our facts … first and fast; be part of our “inner circle” as a subscriber!

Stay with me and join our coalition and have a seat at the appreciation table!

Login Sign up now Not now

content_top

43 companies, 1 interpreter! Insight, foresight
and recommendation

Closing Bell

content_middle

Closing Bell

content_right

September 18, 2019 - 9:58pm | Closing Bell
RegMed Investors’ (RMi) closing bell: trounced again
September 17, 2019 - 7:00pm | Closing Bell
Clone of RegMed Investors’ (RMi) closing bell: the sector turns and burns
September 17, 2019 - 6:59pm | Closing Bell
RegMed Investors’ (RMi) closing bell: the sector turns and burns
September 16, 2019 - 8:14pm | Closing Bell
RegMed Investors’ (RMi) closing bell: yippie-yi-yo-kai-yay
September 13, 2019 - 7:15pm | Closing Bell
RegMed Investors’ (RMi) closing bell: equities fell, not as far but, still down
September 13, 2019 - 6:57am | Closing Bell
RegMed Investors’ (RMi) closing bell: value was torpedoed by electronic trading
September 11, 2019 - 7:41pm | Closing Bell
RegMed Investors’ (RMi) closing bell: a third up sector session
September 10, 2019 - 6:09pm | Closing Bell
RegMed Investors’ (RMi) closing bell: get nervous after two (2) up sector sessions
September 9, 2019 - 7:52pm | Closing Bell
RegMed Investors’ (RMi) closing bell: no real movement from the open
September 8, 2019 - 2:43pm | Closing Bell
RegMed Investors’ (RMi) closing bell: back to a softening sector as the NASDAQ dips
September 5, 2019 - 7:47pm | Closing Bell
RegMed Investors’ (RMi) closing bell: trade and economic news drives the market higher
September 5, 2019 - 7:15am | Closing Bell
RegMed Investors’ (RMi) closing bell: from a negative open to a positive close
September 3, 2019 - 8:30pm | Closing Bell
RegMed Investors’ (RMi) closing bell: Cell and gene therapy equities fell, the first trading day of a historically tough month
August 30, 2019 - 6:39pm | Closing Bell
RegMed Investors’ (RMi) closing bell: the week and August – they’re over
August 29, 2019 - 7:35pm | Closing Bell
RegMed Investors’ (RMi) closing bell: surging sector but, expect the rush upside to subside
August 28, 2019 - 6:32pm | Closing Bell
RegMed Investors’ (RMi) closing bell: as we move through the market’s grounds
August 27, 2019 - 6:47pm | Closing Bell
RegMed Investors’ (RMi) closing bell: when one side of the seesaw empties, the other drops like a stone
August 26, 2019 - 7:21pm | Closing Bell
RegMed Investors’ (RMi) closing bell: the sector in relation to this market, optimism, hesitancy or fatalism, I’m split
August 25, 2019 - 1:02pm | Closing Bell
RegMed Investors’ (RMi) Friday’s closing bell: another sector goose egg of a session
August 22, 2019 - 6:46pm | Closing Bell
RegMed Investors’ (RMi) closing bell: short-term fear has battered the cell and gene therapy sector

Pages

footer

© 2015 RegMed Investors (regmedinvestors.com), all rights are reserved.

RegMed Investors (RMi) or Regmedinvestors.com content is the intellectual property of Henry MCusker . Any copying, republication or redistribution of RMI’s content, including by framing or similar means, is expressly prohibited without the prior written consent of RegMed Investors (RM-i); who also shall not be liable for any errors or delays in content, or for any actions taken in reliance thereon. For additional information on other RM-i media services or reposting please email hwm@regmedinvestors.com.